| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1040734983 |
| P356 | DOI | 10.1385/CRIAI:28:2:115 |
| P698 | PubMed publication ID | 15879618 |
| P2093 | author name string | Ulrich Spengler | |
| Birgit Terjung | |||
| P2860 | cites work | Novel autoantigens of perinuclear anti-neutrophil cytoplasmic antibodies (P-ANCA) in ulcerative colitis: non-histone chromosomal proteins, HMG1 and HMG2 | Q24315869 |
| Isolation and characterization of cDNA encoding a human nuclear antigen predominantly recognized by autoantibodies from patients with primary biliary cirrhosis | Q24322406 | ||
| Autoantibodies from patients with primary biliary cirrhosis recognize a restricted region within the cytoplasmic tail of nuclear pore membrane glycoprotein Gp210 | Q24680278 | ||
| The inner nuclear membrane | Q28144593 | ||
| Wegener's autoantigen decoded | Q28292951 | ||
| Differentiation of antineutrophil nuclear antibodies in inflammatory bowel and autoimmune liver diseases from antineutrophil cytoplasmic antibodies (p-ANCA) using immunofluorescence microscopy | Q28362587 | ||
| Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology | Q29618865 | ||
| Anti-neutrophil cytoplasmic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis | Q29619714 | ||
| Management of primary sclerosing cholangitis | Q30829057 | ||
| Antineutrophil antibodies associated with ulcerative colitis interact with the antigen(s) during the process of apoptosis | Q30881582 | ||
| Atypical antineutrophil cytoplasmic antibodies with perinuclear fluorescence in chronic inflammatory bowel diseases and hepatobiliary disorders colocalize with nuclear lamina proteins | Q32042095 | ||
| Pondering the promyelocytic leukemia protein (PML) puzzle: possible functions for PML nuclear bodies | Q33337386 | ||
| International Consensus Statement on Testing and Reporting of Antineutrophil Cytoplasmic Antibodies (ANCA) | Q33587279 | ||
| International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis | Q33784003 | ||
| The immunopathology of primary biliary cirrhosis: thoughts for the millennium | Q33866358 | ||
| The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore | Q34032261 | ||
| Antineutrophil cytoplasmic autoantibodies in autoimmune liver and inflammatory bowel diseases | Q71678324 | ||
| Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? | Q71741371 | ||
| Autoantibodies | Q71749588 | ||
| A 28-year-old woman with a combined hepatitic/cholestatic syndrome | Q71818799 | ||
| Neutrophil antibodies (pANCA) in chronic liver disease and inflammatory bowel disease: do they react with different antigens? | Q71835861 | ||
| Quantitative measurement of autoantibodies to recombinant mitochondrial antigens in patients with primary biliary cirrhosis: relationship of levels of autoantibodies to disease progression | Q71949347 | ||
| Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis | Q72224539 | ||
| Anti-neutrophil cytoplasmic antibody: a prognostic indicator in primary sclerosing cholangitis | Q72358295 | ||
| Serological classification of chronic cholestatic liver disease by the use of two different types of antimitochondrial antibodies | Q72445844 | ||
| Antimitochondrial antibody-negative primary biliary cirrhosis | Q72524305 | ||
| Antinuclear antibodies in primary biliary cirrhosis | Q72575873 | ||
| Primary autoimmune cholangitis. An alternative to antimitochondrial antibody-negative primary biliary cirrhosis | Q72702326 | ||
| Speckled pattern antinuclear antibodies resembling anticentromere antibodies | Q72721857 | ||
| Positive markers in AMA-negative PBC | Q73012261 | ||
| Detection of IgA, IgM, and IgG subclasses of anti-M2 antibody by immunoblotting in autoimmune cholangitis: is autoimmune cholangitis an early stage of primary biliary cirrhosis? | Q73117434 | ||
| High prevalence of autoimmune hepatitis among patients with primary sclerosing cholangitis | Q73144382 | ||
| Comparison of the clinical features and clinical course of antimitochondrial antibody-positive and -negative primary biliary cirrhosis | Q73319901 | ||
| Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis | Q73319909 | ||
| Serum autoantibodies in patients with primary sclerosing cholangitis | Q73523422 | ||
| Prevalence, kinetics, and therapeutic modulation of autoantibodies against Sp100 and promyelocytic leukemia protein in a large cohort of patients with primary biliary cirrhosis | Q73856978 | ||
| Persistence of gp210 and multiple nuclear dots antibodies does not correlate with recurrence of primary biliary cirrhosis 6 years after liver transplantation | Q74429569 | ||
| Catalase and α-enolase: two novel granulocyte autoantigens in inflammatory bowel disease (IBD) | Q74497730 | ||
| Autoimmune Hepatitis Overlapping With Primary Sclerosing Cholangitis in Five Cases | Q74642745 | ||
| Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: Clinical features and response to therapy | Q77058192 | ||
| Thermolabile and calcium-dependent serum factor interferes with polymerized actin, and impairs anti-actin antibody detection | Q77189631 | ||
| Epitope mapping of cytochrome P4502D6 autoantigen in patients with chronic hepatitis C during alpha-interferon treatment | Q77221647 | ||
| Autoimmune cholangitis and primary biliary cirrhosis--an autoimmune enigma | Q77375780 | ||
| Antineutrophil cytoplasmic antibodies in primary sclerosing cholangitis: defined specificities may be associated with distinct clinical features | Q77609403 | ||
| Value of a screening algorithm for celiac disease using tissue transglutaminase antibodies as first level in a population-based study | Q78498489 | ||
| Celiac disease-associated autoimmune cholangitis | Q78690341 | ||
| Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis | Q34062436 | ||
| Celiac disease in autoimmune cholestatic liver disorders | Q34154921 | ||
| Profile and clinical significance of anti-nuclear envelope antibodies found in patients with primary biliary cirrhosis: a multicenter study | Q34197885 | ||
| LKM-1 autoantibodies recognize a short linear sequence in P450IID6, a cytochrome P-450 monooxygenase | Q34205552 | ||
| Autoimmune overlap syndromes | Q34205699 | ||
| Patients with primary biliary cirrhosis react against a ubiquitous xenobiotic-metabolizing bacterium | Q34272356 | ||
| Anti-lactoferrin antibodies and other types of ANCA in ulcerative colitis, primary sclerosing cholangitis, and Crohn's disease. | Q34376222 | ||
| Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis | Q34377943 | ||
| Frequency and significance of anti-gliadin and anti-endomysial antibodies in autoimmune hepatitis | Q34477251 | ||
| Different types of smooth muscle antibodies in chronic active hepatitis and primary biliary cirrhosis: their diagnostic and prognostic significance | Q34494107 | ||
| Serum autoantibodies, ulcerative colitis and primary sclerosing cholangitis | Q34528389 | ||
| Major antigen of liver kidney microsomal autoantibodies in idiopathic autoimmune hepatitis is cytochrome P450db1. | Q34569386 | ||
| The diagnostic value of anti-mitochondrial antibodies, especially in primary biliary cirrhosis | Q34657098 | ||
| High mobility group (HMG) non-histone chromosomal proteins HMG1 and HMG2 are significant target antigens of perinuclear anti-neutrophil cytoplasmic antibodies in autoimmune hepatitis | Q35355488 | ||
| Autoantibodies in the Diagnosis and Management of Liver Disease | Q35541984 | ||
| Identification of a major polypeptide of the nuclear pore complex | Q36209313 | ||
| Autoimmune cholangitis in the SJL/J mouse is antigen non-specific | Q36511479 | ||
| Differences in immune recognition of cytochrome P4502D6 by liver kidney microsomal (LKM) antibody in autoimmune hepatitis and chronic hepatitis C virus infection | Q36734483 | ||
| Primary biliary cirrhosis: paradigm or paradox for autoimmunity | Q37637964 | ||
| Antimitochondrial antibodies in primary biliary cirrhosis | Q38160194 | ||
| Molecular definitions, autoepitopes, and enzymatic activities of the mitochondrial autoantigens of primary biliary cirrhosis | Q38203013 | ||
| Use of a designer triple expression hybrid clone for three different lipoyl domain for the detection of antimitochondrial autoantibodies | Q38355919 | ||
| Characterization of the overlap syndrome of primary biliary cirrhosis (PBC) and autoimmune hepatitis: evidence for it being a hepatitic form of PBC in genetically susceptible individuals | Q39225838 | ||
| The significance of natural autoantibodies | Q39545251 | ||
| Smooth muscle autoantibodies and autoantigens | Q39587588 | ||
| Primary biliary cirrhosis and mitochondrial autoantigens--insights from molecular biology | Q39626983 | ||
| Formalin fixation and patterns of antineutrophil cytoplasmic antibodies | Q39639674 | ||
| Bactericidal/permeability-increasing protein (BPI) is an important antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in vasculitis | Q40564213 | ||
| ANCA and associated diseases: immunodiagnostic and pathogenetic aspects | Q40868442 | ||
| Antineutrophil cytoplasmic antibodies in chronic liver diseases: prevalence, titre, specificity and IgG subclass. | Q40940548 | ||
| Autoantibodies from patients with primary biliary cirrhosis preferentially react with the amino-terminal domain of nuclear pore complex glycoprotein gp210. | Q40971480 | ||
| A 2-year follow-up study of anti-neutrophil antibody in primary sclerosing cholangitis: relationship to clinical activity, liver biochemistry and ursodeoxycholic acid treatment | Q41011627 | ||
| Classification of smooth muscle autoantibodies detected by immunofluorescence | Q41243939 | ||
| Two Nuclear Dot‐Associated Proteins, PML and SplOO, are Often Co‐Autoimmunogenic in Patients with Primary Biliary Cirrhosis | Q41318611 | ||
| Antimitochondrial antibodies in primary biliary cirrhosis. | Q41412932 | ||
| Nuclear envelope protein autoantibodies in primary biliary cirrhosis | Q41412977 | ||
| A critical evaluation of enzyme immunoassays for detection of antinuclear autoantibodies of defined specificities. I. Precision, sensitivity, and specificity | Q41615585 | ||
| Anti-nuclear antibodies of primary biliary cirrhosis recognize 78-92-kD and 96-100-kD proteins of nuclear bodies | Q41696726 | ||
| Identification of histone H1 as a cognate antigen of the ulcerative colitis-associated marker antibody pANCA. | Q41716166 | ||
| "Atypical p-ANCA" in IBD and hepatobiliary disorders react with a 50-kilodalton nuclear envelope protein of neutrophils and myeloid cell lines | Q41752982 | ||
| Analysis of the hepatitis C virus genome in patients with anti-LKM-1 autoantibodies | Q43041953 | ||
| Celiac disease in patients with severe liver disease: gluten-free diet may reverse hepatic failure | Q43557858 | ||
| Detection of antimitochondrial autoantibodies in immunofluorescent AMA-negative patients with primary biliary cirrhosis using recombinant autoantigens | Q43693265 | ||
| Antimitochondrial antibody profiles: are they valid prognostic indicators in primary biliary cirrhosis? | Q43988210 | ||
| Chronic active hepatitis associated with antiliver/kidney microsome antibody type 1: a second type of "autoimmune" hepatitis | Q44086661 | ||
| PBC 95k, a 95-kilodalton nuclear autoantigen in primary biliary cirrhosis | Q44411171 | ||
| Antineutrophil cytoplasmic antibodies (ANCA) directed against cathepsin G in ulcerative colitis, Crohn's disease and primary sclerosing cholangitis | Q44663102 | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates | Q45077280 | ||
| Liver/kidney microsome antibody type 1 and hepatitis C virus infection | Q45872748 | ||
| High-titer antineutrophil cytoplasmic antibodies in type-1 autoimmune hepatitis | Q45998281 | ||
| Persistence of Autoantibodies against Recombinant Mitochondrial and Nuclear Pore Proteins after Orthotopic Liver Transplantation for Primary Biliary Cirrhosis | Q46074238 | ||
| Neutrophil cytoplasmic antibodies: a link between primary sclerosing cholangitis and ulcerative colitis | Q46083582 | ||
| Antimitochondrial antibodies of primary biliary cirrhosis recognize dihydrolipoamide acyltransferase and inhibit enzyme function of the branched chain alpha-ketoacid dehydrogenase complex | Q46364659 | ||
| Identification and characterization of autoantibodies against catalase and α-enolase in patients with primary sclerosing cholangitis | Q47901377 | ||
| The antinuclear autoantibodies Sp100 and gp210 persist after orthotopic liver transplantation in patients with primary biliary cirrhosis | Q47979411 | ||
| Antineutrophil nuclear antibodies (ANNA) in primary biliary cirrhosis: their prevalence and antigen specificity | Q50753509 | ||
| Immune phenotype of chronic liver disease | Q50864814 | ||
| Celiac disease in autoimmune cholestatic liver disorders | Q56428274 | ||
| 'True' antimitochondrial antibody-negative primary biliary cirrhosis, low sensitivity of the routine assays, or both? | Q57002652 | ||
| Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis | Q57004434 | ||
| Anti-neutrophil cytoplasmic antibodies in ulcerative colitis | Q59882811 | ||
| A critical evaluation of enzyme immunoassay kits for detection of antinuclear autoantibodies of defined specificities. II. Potential for quantitation of antibody content | Q64128512 | ||
| Autoantibodies to the nuclear Sp100 protein in primary biliary cirrhosis and associated diseases: epitope specificity and immunoglobulin class distribution | Q67544050 | ||
| Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis | Q67553678 | ||
| Significance and specificity of antibodies to neutrophils detected by western blotting for the serological diagnosis of primary sclerosing cholangitis | Q67705022 | ||
| Primary sclerosing cholangitis and celiac disease. A novel association | Q67966813 | ||
| Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis | Q68149092 | ||
| Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis | Q68512872 | ||
| Cytoskeleton Antibodies in Chronic Active Hepatitis, Primary Biliary Cirrhosis, and Alcoholic Liver Disease | Q70250764 | ||
| Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis | Q70331416 | ||
| Prevalence and characterization of neutrophil cytoplasmic antibodies in autoimmune liver diseases | Q70588163 | ||
| Antineutrophil cytoplasmic autoantibodies in inflammatory bowel disease | Q70595133 | ||
| Antineutrophil cytoplasmic antibody in inflammatory bowel and hepatobiliary diseases. High prevalence in ulcerative colitis, primary sclerosing cholangitis, and autoimmune hepatitis | Q70595160 | ||
| Autoantibody profile of primary sclerosing cholangitis | Q70882298 | ||
| Azurocidin is a novel antigen for anti-neutrophil cytoplasmic autoantibodies (ANCA) in systemic vasculitis | Q71018500 | ||
| Specificity and sensitivity of gp210 autoantibodies detected using an enzyme-linked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis | Q71057890 | ||
| Clinicopathologic features of the syndrome of primary sclerosing cholangitis | Q71266771 | ||
| Segregation of autoantibody to cytoskeletal filaments, actin and intermediate filaments with two types of chronic active hepatitis | Q71438460 | ||
| Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis | Q71598504 | ||
| Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis | Q71603498 | ||
| Detection of Gp210 autoantibodies in primary biliary cirrhosis using a recombinant protein containing the predominant autoepitope | Q71671839 | ||
| P433 | issue | 2 | |
| P304 | page(s) | 115-133 | |
| P577 | publication date | 2005-04-01 | |
| P13046 | publication type of scholarly work | review article | Q7318358 |
| P1433 | published in | Clinical Reviews in Allergy & Immunology | Q1932354 |
| P1476 | title | Role of auto-antibodies for the diagnosis of chronic cholestatic liver diseases | |
| P478 | volume | 28 |
| Q33594857 | Angiocentric lesions of the head and neck |
| Q34178879 | Association between chronic liver and colon inflammation during the development of murine syngeneic graft-versus-host disease |
| Q38889147 | Autoantibodies in Autoimmune Liver Diseases-Methods of Detection and Interpretation: An Update for the Reporting Pathologist |
| Q27489093 | Autoantibodies in primary sclerosing cholangitis |
| Q92465727 | British Society of Gastroenterology and UK-PSC guidelines for the diagnosis and management of primary sclerosing cholangitis |
| Q44700797 | Demonstration of autoantibodies to recombinant human sulphite oxidase in patients with chronic liver disorders and analysis of their clinical relevance |
| Q46669235 | Evaluation of an automated chemiluminescent immunoassay kit for antinuclear antibodies in autoimmune diseases |
| Q37905969 | Hepatobiliary disorders and complications of inflammatory bowel disease |
| Q37317444 | Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver. |
| Q26829300 | Hepatobiliary manifestations of ulcerative colitis: an example of gut-liver crosstalk |
| Q37701805 | Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease |
| Q42122089 | Liver disorders in inflammatory bowel disease |
| Q37182958 | Overlap syndromes among autoimmune liver diseases |
| Q57116825 | Primary sclerosing cholangitis |
| Q90364948 | The search for the Holy Grail: autoantigenic targets in primary sclerosing cholangitis associated with disease phenotype and neoplasia |
Search more.